Find an Alzheimer's clinical trial

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Search title, drug, condition or sponsor

Recruiting

Exact registry status

Phase

Intervention class

Study type

Country

Results per page

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 7,276–7,300 of 7,816 matching trials · page 292 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial	Phase	Status	Enrolled	Sponsor	Last updated
Behavioral Sleep Intervention in Adult Family Homes NCT00393627 Sleep Education Program Runs in: United States · 1 site	PHASE2 other	COMPLETED	47	University of Washington OTHER	2012-06-14
The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease NCT00548145 Pitavastatin; cholesterol-lowering medicine other than statin(e.g.,... Runs in: Japan · 1 site	NA other	TERMINATED	38	Osaka University OTHER	2012-06-14
Effects of ONO-2506PO in Patients With Alzheimer's Disease NCT00083421 ONO-2506PO Runs in: Canada; United States · 87 sites	PHASE2 other	COMPLETED	647	Ono Pharma USA Inc INDUSTRY	2012-06-13
Computerised Testing of Cognitive Response to Cerebrospinal Fluid Shunting in Idiopathic Normal Pressure Hydrocephalus NCT01618500 Runs in: Denmark; Sweden · 4 sites	NA other	UNKNOWN	80	Umeå University OTHER	2012-06-13
Person- Centred Care Among Nursing Home Patients With Dementia NCT01280890 Staff training using VIPS; Staff training using DCM; Control group	NA other	COMPLETED	624	Norwegian Centre for Ageing and Health OTHER	2012-06-12
PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus NCT01053312 [18F] Flutemetamol Runs in: United States · 1 site	PHASE3 other	COMPLETED	7	GE Healthcare INDUSTRY	2012-06-11
A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease NCT00087724 FK962 Runs in: Canada; United States · 84 sites	PHASE2 other	TERMINATED	510	Astellas Pharma Inc INDUSTRY	2012-06-07
Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease NCT00842673 ST101; ST101; ST101; Placebo Runs in: Canada; United States · 18 sites	PHASE2 other	COMPLETED	168	Sonexa Therapeutics, Inc. INDUSTRY	2012-06-07
Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease NCT00842816 ST101; ST101; ST101; Placebo Runs in: Canada; United States · 30 sites	PHASE2 other	COMPLETED	210	Sonexa Therapeutics, Inc. INDUSTRY	2012-06-07
Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans NCT01550549 florbetapir F 18	NA other	COMPLETED	151	Avid Radiopharmaceuticals INDUSTRY	2012-06-07
Evaluation of PET Scan Timing Relative to AV-45 Injection Time NCT01565356 florbetapir F 18	NA other	COMPLETED	41	Avid Radiopharmaceuticals INDUSTRY	2012-06-07
Evaluation of Physician Training Methods to Read Florbetapir-PET Scans NCT01565369 florbetapir F 18	NA other	COMPLETED	35	Avid Radiopharmaceuticals INDUSTRY	2012-06-07
An Imaging Study to Investigate the Distribution of GSK239512 in the Brain. NCT00474513 GSK239512 Runs in: Canada · 1 site	PHASE1 other	COMPLETED	5	GlaxoSmithKline INDUSTRY	2012-06-04
Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia NCT00594737 memantine hydrochloride Runs in: Canada · 1 site	PHASE3 symptomatic-cholinergic	COMPLETED	17	Tiffany Chow, MD OTHER	2012-06-04
Driving Ability Among People With Mild Cognitive Impairment NCT01608256 Runs in: Israel · 1 site	NA other	UNKNOWN	60	Tel Aviv University OTHER	2012-05-31
Early Intervention in Mild Cognitive Impairment (MCI) With Curcumin + Bioperine NCT00595582 curcumin + bioperine Runs in: United States · 1 site	NA other	TERMINATED	10	Louisiana State University Health Sciences Center Shreveport OTHER	2012-05-28
Mindfulness Based Stress Reduction for Adults With Mild Cognitive Impairment NCT01605448 Mindfulness Based Stress Reduction (MBSR) Runs in: United States · 1 site	NA other	COMPLETED	14	Beth Israel Deaconess Medical Center OTHER	2012-05-24
Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain NCT00857415 florbetapir F 18 Runs in: United States · 25 sites	PHASE3 other	COMPLETED	226	Avid Radiopharmaceuticals INDUSTRY	2012-05-22
A Study of 18F-AV-45 in Healthy Volunteers NCT01564706 florbetapir F 18 Runs in: United States · 1 site	PHASE1 other	COMPLETED	9	Avid Radiopharmaceuticals INDUSTRY	2012-05-18
A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers NCT01565291 florbetapir F 18 Runs in: United States · 3 sites	EARLY_PHASE1 other	COMPLETED	32	Avid Radiopharmaceuticals INDUSTRY	2012-05-18
A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV NCT01599975 Long acting methylphenidate; Long acting methylphenidate; Matched placebo Runs in: United States · 1 site	PHASE3 other	UNKNOWN	40	University of California, Los Angeles OTHER	2012-05-16
A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) NCT00702143 florbetapir F 18 Runs in: United States · 15 sites	PHASE2 other	COMPLETED	184	Avid Radiopharmaceuticals INDUSTRY	2012-05-10
A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers NCT01565343 florbetapir F 18 Runs in: United States · 4 sites	PHASE1 other	COMPLETED	25	Avid Radiopharmaceuticals INDUSTRY	2012-05-10
Safety Study of Passive Immunization for Patients With Mild to Moderate Alzheimer's Disease NCT00174525 AAB-001 Runs in: United States · 2 sites	PHASE2 other	UNKNOWN	—	Pharmacology Research Institute OTHER	2012-05-09
Enhancing Quality of Life for Nursing Home Residents NCT00388544 Activity matched to interest; Activity matched to function; Activit... Runs in: United States · 1 site	PHASE2 other	COMPLETED	128	Penn State University OTHER	2012-05-09

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry: ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file: 7,816
Source file: trials.csv (3.8 MB, 7816 rows)
Basis: Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024 · score 88/100
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial The Lancet. Neurology, 2026 · score 86/100
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial Lancet (London, England), 2021 · score 86/100
Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease Journal of Alzheimer's disease : JAD, 2026 · score 86/100
Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial EBioMedicine, 2024 · score 85/100

All 162 studies on Clinical trials →